About Osmopharm
Osmopharm is a Healthcare company based in Lugano (Switzerland) founded in 1994, and was acquired by SPIMACO in November 2023. It operates as a manufacturer of heavy-duty CNC milling and drilling machines. Osmopharm offers products and services including Pellets, Ion-exchange resinates, and Blistering and packaging. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Osmopharm SA.
Company details
Founded in 1994 in Lugano, Switzerland, Osmopharm operates in the industrial machinery sector, focusing on heavy-duty CNC milling and drilling machines for large-scale manufacturing. Custom and turnkey solutions are provided, along with an inventory program for expedited delivery of stock machines and parts. Services include preventative maintenance, retrofitting, rebuilding, tooling, training, and optimization to support operational efficiency. Machines are designed to enhance accuracy and throughput while optimizing floor space.
- Headquarters Lugano, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website osmopharm.com/home
- Social LinkedIn
- Acquired by SPIMACO (Nov 2023)
- Legal Name Osmopharm Sa
Products & Services of Osmopharm
Osmopharm offers a comprehensive portfolio of products and services, including Pellets, Ion-exchange resinates, and Blistering and packaging.
Modified release pellets for oral drug delivery systems.
Resinates used in drug formulation and release control.
Services for pharmaceutical product packaging and protection.
Investors in Osmopharm
Osmopharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SPIMACO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tablets, capsules, syrups, creams, and injectables are manufactured. | 1986 | spimaco.com.sa | Riyadh, Saudi Arabia |
Investor details for Osmopharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Osmopharm
2 dated milestones of Osmopharm across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Osmopharm is founded.
- Exit Acquired by SPIMACO.
Web traffic of Osmopharm
The website of Osmopharm (osmopharm.com) receives about 1.6K visits a month and ranks #13,948,426 among all websites worldwide, #8,507 in Biotechnology and Pharmaceuticals.
- Monthly visits1.6K
▲ 46% vs previous month
- Global rank#13,948,426
among all websites
- Category rank#8,507
Health · Biotechnology and Pharmaceuticals
- Bounce rate46%
- Pages per visit1.1
- DevicesDesktop 35% · Mobile 65%
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Osmopharm (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Osmopharm
Complete news archive for Osmopharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osmopharm
Osmopharm was founded in 1994.
Osmopharm is headquartered in Lugano, Switzerland. It is registered at Lugano, Ticino, Switzerland.
Founded in 1994 in Lugano, Switzerland, Osmopharm operates in the industrial machinery sector, focusing on heavy-duty CNC milling and drilling machines for large-scale manufacturing. Custom and turnkey solutions are provided, along with an inventory program for expedited delivery of stock machines and parts. Services include preventative maintenance, retrofitting, rebuilding, tooling, training, and optimization to support operational efficiency. Machines are designed to enhance accuracy and throughput while optimizing floor space.
Osmopharm offers Pellets, Ion-exchange resinates, and Blistering and packaging.
Osmopharm has 1 investor. Key investors include SPIMACO.
Osmopharm operates through Osmopharm Sa.
Yes. Osmopharm was acquired by SPIMACO in November 2023.